Leading Companies in the Global Sodium Starch Glycolate Market to 2025

Published Date : 2025-Jul-21

Sodium Starch Glycolate — a critical superdisintegrant used in pharmaceutical tablets and capsules — plays a quiet yet powerful role in the global pharma supply chain.

The Global Sodium Starch Glycolate Market is expanding as demand for fast-dissolving, effective drug delivery solutions accelerates.

The market is estimated to reach $113.83 Million by 2028, growing at a CAGR of 7.02% from 2022 to 2028.

Here is a list of the leading companies shaping this industry.


Market Overview:

IMIR Market Research, is thrilled to post its latest insights Leading Companies Blog 2025 on "Global Sodium Starch Glycolate Market" – Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, [2022-2028].

The Market size was valued at USD 70.42 Million in 2021 and is projected to reach USD 113.83 Million by 2028, growing at a CAGR of 7.02% from 2021 to 2028.

Market Leaders: DFE Pharma, JRS Pharma, Roquette, Sunhere, and Shreeji Pharma.

Asia-Pacific: Leading producer 

 

Market Drivers

  • Rising global pharmaceutical production, especially generic tablets.

  • Growing demand for orally disintegrating tablets (ODTs) and fast-release formulations.

  • Expansion of contract manufacturing and third-party drug production.

  • Regulatory push for high-quality excipients in developed and emerging markets.

  • Advancements in SSG grades for enhanced performance and bioavailability.

 

Current Growth Trends 2025

  • Surge in demand for non-GMO and plant-based SSG grades.

  • Growth in R&D for high-efficiency superdisintegrants.

  • Increasing adoption in veterinary and nutraceutical tablet segments.

  • New supply chain investments to ensure raw material quality and availability.

 

Would you like me to add more details on specific companies or market trends? Let me know! CLICK HERE

 

Leading Companies in the Sodium Starch Glycolate Market

Below are the top companies shaping the SSG landscape.

DFE Pharma

 
  • Headquarters: Goch, Germany

  • Founded: 1908

  • Employees: ~1,000 (2024)

  • Revenue 2024: ~$350 Million USD

 

JRS Pharma (J. Rettenmaier & Söhne)

 
  • Headquarters: Rosenberg, Germany

  • Founded: 1878

  • Employees: ~3,500 (2024)

  • Revenue 2024: ~$500 Million USD

 

Roquette Frères

  • Headquarters: Lestrem, France

  • Founded: 1933

  • Employees: ~8,800 (2024)

  • Revenue 2024: ~$4 Billion USD

 

Shreeji Pharma International

 
  • Headquarters: Ahmedabad, India

  • Founded: 2004

  • Employees: ~150 (2024)

  • Revenue 2024: ~$25 Million USD

 

Maruti Chemicals

  • Headquarters: Mumbai, India

  • Founded: 2015

  • Employees: ~50

  • Revenue 2024: ~$5 Million USD

And More Companies........

 

Segmentation Analysis

By Source:

  • SSG (Corn Starch)
  • SSG (Potato Starch)
  • SSG (Others)

By Application:

  • Pharmaceuticals (tablets & capsules)
  • Food
  • Nutraceuticals
  • Veterinary Medicine

By Form:

  • Type A (Alkaline process)

  • Type B (Acid process)

 

Regional Analysis

  • Asia-Pacific: Leading producer with India and China dominating supply.

  • Europe: Major demand driven by advanced pharmaceutical manufacturers.

  • North America: Steady growth, fueled by generics and R&D investments.

  • Latin America & MEA: Gradual adoption with growing local pharma production.

 

Growth And Trends 2025

  • High-purity grades for regulated markets.

  • Investment in GMP-certified production facilities.

  • Sustainable sourcing of starch raw materials.

  • Expansion into new dosage forms like dispersible tablets.

 

The Global Sodium Starch Glycolate Market is set to grow steadily through 2025 as demand for high-quality tablet disintegration solutions rises across the pharmaceutical and nutraceutical sectors. Both global leaders and agile startups are innovating to meet strict quality and sustainability standards.

 

Frequently Asked Questions (FAQs)

Q1: What is Sodium Starch Glycolate used for?
Answer: It’s a superdisintegrant used in tablets and capsules to help them break down quickly after swallowing.

Q2: Why is demand growing?
Answer: The rise in generic drugs, ODTs, and patient preference for fast-acting medications.

Q3: Who are the market leaders?
Answer: DFE Pharma, JRS Pharma, Roquette, Sunhere, and Shreeji Pharma.

Q4: Which region dominates?
Answer: Asia-Pacific leads in production, Europe and North America drive regulated demand.

Q5: What’s new in this market?
Answer: Non-GMO, plant-based grades and advanced manufacturing for high-performance formulations.

 

#IMIR #IMIRMarketResearch #SodiumStarchGlycolate #PharmaExcipients #TabletFormulation #Generics #FastDisintegrants #MarketResearch 

 


About US:

IMIR Market Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.

Contact Us: IMIR Market Research Pvt. Ltd.

Email: sales@intellectualmarketinsights.com

Call Us: +1 (814) 487 8486

To Gain Further Insights on
this Market, Write Us: